Ambev faces stagnant growth and an overvalued P/E ratio. Learn why ABEV stock is rated a sell due to limited prospects and ...

Dowling outlined three strategic growth areas: product innovation, cost-efficiency improvements, and M&A activities. He highlighted the launch of the Plus Health product line, which includes ...